Listed

VivoSim Labs, INC.

VIVSNasdaqCIK 1497253HealthcareFiscal year ends Mar 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$18.0k, Q1 FY2027
Operating income−$2.8m, Q1 FY2027
Net income−$1.3m, Q1 FY2027
VivoSim Labs, INC., income statement, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30
Revenue$k0.0Revenue, Q2 FY2024, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure5.0Revenue, Q3 FY2024, three months to 2023-12-31$5.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure29.0Revenue, Q4 FY2024, three months to 2024-03-31$29.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-06-05, accession 0000950170-25-082312. Derived: 12-month figure less the 9-month figure.Report this figure39.0Revenue, Q1 FY2025, three months to 2024-06-30$39.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure30.0Revenue, Q2 FY2025, three months to 2024-09-30$30.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure24.0Revenue, Q3 FY2025, three months to 2024-12-31$24.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure51.0Revenue, Q4 FY2025, three months to 2025-03-31$51.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure37.0Revenue, Q1 FY2026, three months to 2025-06-30$37.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure28.0Revenue, Q2 FY2026, three months to 2025-09-30$28.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure26.0Revenue, Q3 FY2026, three months to 2025-12-31$26.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure40.0Revenue, Q4 FY2026, three months to 2026-03-31$40.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure18.0Revenue, Q1 FY2027, three months to 2026-06-30$18.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Cost of revenue$k0.0Cost of revenue, Q2 FY2024, three months to 2023-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure0.0Cost of revenue, Q3 FY2024, three months to 2023-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figurenot reported2.0Cost of revenue, Q1 FY2025, three months to 2024-06-30$2.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure1.0Cost of revenue, Q2 FY2025, three months to 2024-09-30$1.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure2.0Cost of revenue, Q3 FY2025, three months to 2024-12-31$2.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure0.0Cost of revenue, Q4 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2026, three months to 2025-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure0.0Cost of revenue, Q2 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure0.0Cost of revenue, Q3 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure0.0Cost of revenue, Q4 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figurenot reported
Research and development$k1,335Research and development, Q2 FY2024, three months to 2023-09-30$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure1,434Research and development, Q3 FY2024, three months to 2023-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure1,063Research and development, Q4 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-06-05, accession 0000950170-25-082312. Derived: 12-month figure less the 9-month figure.Report this figure1,402Research and development, Q1 FY2025, three months to 2024-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure984Research and development, Q2 FY2025, three months to 2024-09-30$984.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure1,780Research and development, Q3 FY2025, three months to 2024-12-31$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure859Research and development, Q4 FY2025, three months to 2025-03-31$859.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure1,001Research and development, Q1 FY2026, three months to 2025-06-30$1.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure923Research and development, Q2 FY2026, three months to 2025-09-30$923.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure1,140Research and development, Q3 FY2026, three months to 2025-12-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure1,125Research and development, Q4 FY2026, three months to 2026-03-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure1,132Research and development, Q1 FY2027, three months to 2026-06-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Selling, general and administrative$k2,780Selling, general and administrative, Q2 FY2024, three months to 2023-09-30$2.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure2,251Selling, general and administrative, Q3 FY2024, three months to 2023-12-31$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure2,062Selling, general and administrative, Q4 FY2024, three months to 2024-03-31$2.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-06-05, accession 0000950170-25-082312. Derived: 12-month figure less the 9-month figure.Report this figure2,021Selling, general and administrative, Q1 FY2025, three months to 2024-06-30$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure1,653Selling, general and administrative, Q2 FY2025, three months to 2024-09-30$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure1,710Selling, general and administrative, Q3 FY2025, three months to 2024-12-31$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure2,346Selling, general and administrative, Q4 FY2025, three months to 2025-03-31$2.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure1,951Selling, general and administrative, Q1 FY2026, three months to 2025-06-30$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure1,740Selling, general and administrative, Q2 FY2026, three months to 2025-09-30$1.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure1,636Selling, general and administrative, Q3 FY2026, three months to 2025-12-31$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure2,102Selling, general and administrative, Q4 FY2026, three months to 2026-03-31$2.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure1,645Selling, general and administrative, Q1 FY2027, three months to 2026-06-30$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Operating income$k(4,115)Operating income, Q2 FY2024, three months to 2023-09-30−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure(3,680)Operating income, Q3 FY2024, three months to 2023-12-31−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure(3,096)Operating income, Q4 FY2024, three months to 2024-03-31−$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-06-05, accession 0000950170-25-082312. Derived: 12-month figure less the 9-month figure.Report this figure(3,386)Operating income, Q1 FY2025, three months to 2024-06-30−$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure(2,608)Operating income, Q2 FY2025, three months to 2024-09-30−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure(3,468)Operating income, Q3 FY2025, three months to 2024-12-31−$3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure(3,154)Operating income, Q4 FY2025, three months to 2025-03-31−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure(2,915)Operating income, Q1 FY2026, three months to 2025-06-30−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure(2,635)Operating income, Q2 FY2026, three months to 2025-09-30−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure(2,750)Operating income, Q3 FY2026, three months to 2025-12-31−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure(3,187)Operating income, Q4 FY2026, three months to 2026-03-31−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure(2,759)Operating income, Q1 FY2027, three months to 2026-06-30−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Interest expense$knot reported0.0Interest expense, Q3 FY2024, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figurenot reported0.0Interest expense, Q1 FY2025, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure0.0Interest expense, Q2 FY2025, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure5.0Interest expense, Q3 FY2025, three months to 2024-12-31$5.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure5.0Interest expense, Q4 FY2025, three months to 2025-03-31$5.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure4.0Interest expense, Q1 FY2026, three months to 2025-06-30$4.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure0.0Interest expense, Q2 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure4.0Interest expense, Q3 FY2026, three months to 2025-12-31$4.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure4.0Interest expense, Q4 FY2026, three months to 2026-03-31$4.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure4.0Interest expense, Q1 FY2027, three months to 2026-06-30$4.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Income tax$k0.0Income tax, Q2 FY2024, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure0.0Income tax, Q3 FY2024, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-06-05, accession 0000950170-25-082312. Derived: 12-month figure less the 9-month figure.Report this figure2.0Income tax, Q1 FY2025, three months to 2024-06-30$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure0.0Income tax, Q2 FY2025, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure0.0Income tax, Q3 FY2025, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure2.0Income tax, Q2 FY2026, three months to 2025-09-30$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure0.0Income tax, Q3 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure0.0Income tax, Q4 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure3.0Income tax, Q1 FY2027, three months to 2026-06-30$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Net income$k(3,994)Net income, Q2 FY2024, three months to 2023-09-30−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure(3,604)Net income, Q3 FY2024, three months to 2023-12-31−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure(3,045)Net income, Q4 FY2024, three months to 2024-03-31−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-06-05, accession 0000950170-25-082312. Derived: 12-month figure less the 9-month figure.Report this figure(3,344)Net income, Q1 FY2025, three months to 2024-06-30−$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure(2,549)Net income, Q2 FY2025, three months to 2024-09-30−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure(3,447)Net income, Q3 FY2025, three months to 2024-12-31−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure6,852Net income, Q4 FY2025, three months to 2025-03-31$6.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure(2,843)Net income, Q1 FY2026, three months to 2025-06-30−$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure(2,545)Net income, Q2 FY2026, three months to 2025-09-30−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure(2,691)Net income, Q3 FY2026, three months to 2025-12-31−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure(5,764)Net income, Q4 FY2026, three months to 2026-03-31−$5.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure(1,338)Net income, Q1 FY2027, three months to 2026-06-30−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Diluted EPS$ per share(0.46)Diluted EPS, Q2 FY2024, three months to 2023-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure(0.40)Diluted EPS, Q3 FY2024, three months to 2023-12-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figurenot reported(2.74)Diluted EPS, Q1 FY2025, three months to 2024-06-30−$2.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure(1.68)Diluted EPS, Q2 FY2025, three months to 2024-09-30−$1.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure(2.28)Diluted EPS, Q3 FY2025, three months to 2024-12-31−$2.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figurenot reported(1.14)Diluted EPS, Q1 FY2026, three months to 2025-06-30−$1.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure(0.98)Diluted EPS, Q2 FY2026, three months to 2025-09-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure(1.03)Diluted EPS, Q3 FY2026, three months to 2025-12-31−$1.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figurenot reported(0.25)Diluted EPS, Q1 FY2027, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Basic EPS$ per share(0.46)Basic EPS, Q2 FY2024, three months to 2023-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure(0.40)Basic EPS, Q3 FY2024, three months to 2023-12-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figurenot reported(2.74)Basic EPS, Q1 FY2025, three months to 2024-06-30−$2.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure(1.68)Basic EPS, Q2 FY2025, three months to 2024-09-30−$1.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure(2.28)Basic EPS, Q3 FY2025, three months to 2024-12-31−$2.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figurenot reported(1.14)Basic EPS, Q1 FY2026, three months to 2025-06-30−$1.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure(0.98)Basic EPS, Q2 FY2026, three months to 2025-09-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure(1.03)Basic EPS, Q3 FY2026, three months to 2025-12-31−$1.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figurenot reported(0.25)Basic EPS, Q1 FY2027, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure

Balance sheet

Cash and equivalents$1.7m, Q1 FY2027
Shareholders' equity−$2.3m, Q1 FY2027
VivoSim Labs, INC., balance sheet, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31FY20262026-03-31Q1 FY20272026-06-30
Cash and equivalents$m7.6Cash and equivalents, Q2 FY2024, at 2023-09-30$7.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure5.3Cash and equivalents, Q3 FY2024, at 2023-12-31$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure2.9Cash and equivalents, FY2024, at 2024-03-31$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-06-05, accession 0000950170-25-082312.Report this figure6.2Cash and equivalents, Q1 FY2025, at 2024-06-30$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure3.2Cash and equivalents, Q2 FY2025, at 2024-09-30$3.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure1.2Cash and equivalents, Q3 FY2025, at 2024-12-31$1.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure11.3Cash and equivalents, FY2025, at 2025-03-31$11.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-07-14, accession 0001193125-26-303316.Report this figure9.1Cash and equivalents, Q1 FY2026, at 2025-06-30$9.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure6.7Cash and equivalents, Q2 FY2026, at 2025-09-30$6.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure4.3Cash and equivalents, Q3 FY2026, at 2025-12-31$4.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure5.0Cash and equivalents, FY2026, at 2026-03-31$5.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure1.7Cash and equivalents, Q1 FY2027, at 2026-06-30$1.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Current assets$m8.3Current assets, Q2 FY2024, at 2023-09-30$8.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062228.Report this figure6.2Current assets, Q3 FY2024, at 2023-12-31$6.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-08, accession 0000950170-24-012754.Report this figure3.9Current assets, FY2024, at 2024-03-31$3.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-06-05, accession 0000950170-25-082312.Report this figure7.3Current assets, Q1 FY2025, at 2024-06-30$7.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-05, accession 0000950170-24-090726.Report this figure4.8Current assets, Q2 FY2025, at 2024-09-30$4.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure2.1Current assets, Q3 FY2025, at 2024-12-31$2.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure12.1Current assets, FY2025, at 2025-03-31$12.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-07-14, accession 0001193125-26-303316.Report this figure9.7Current assets, Q1 FY2026, at 2025-06-30$9.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure7.6Current assets, Q2 FY2026, at 2025-09-30$7.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure6.0Current assets, Q3 FY2026, at 2025-12-31$6.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure6.6Current assets, FY2026, at 2026-03-31$6.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure3.2Current assets, Q1 FY2027, at 2026-06-30$3.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Total assets$m11.2Total assets, Q2 FY2024, at 2023-09-30$11.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062228.Report this figure8.9Total assets, Q3 FY2024, at 2023-12-31$8.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-08, accession 0000950170-24-012754.Report this figure6.3Total assets, FY2024, at 2024-03-31$6.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-06-05, accession 0000950170-25-082312.Report this figure9.5Total assets, Q1 FY2025, at 2024-06-30$9.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-05, accession 0000950170-24-090726.Report this figure6.8Total assets, Q2 FY2025, at 2024-09-30$6.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure3.8Total assets, Q3 FY2025, at 2024-12-31$3.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure14.7Total assets, FY2025, at 2025-03-31$14.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-07-14, accession 0001193125-26-303316.Report this figure12.0Total assets, Q1 FY2026, at 2025-06-30$12.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure9.7Total assets, Q2 FY2026, at 2025-09-30$9.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure7.0Total assets, Q3 FY2026, at 2025-12-31$7.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure7.4Total assets, FY2026, at 2026-03-31$7.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure3.8Total assets, Q1 FY2027, at 2026-06-30$3.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Current liabilities$m1.6Current liabilities, Q2 FY2024, at 2023-09-30$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062228.Report this figure1.7Current liabilities, Q3 FY2024, at 2023-12-31$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-08, accession 0000950170-24-012754.Report this figure1.9Current liabilities, FY2024, at 2024-03-31$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-06-05, accession 0000950170-25-082312.Report this figure2.0Current liabilities, Q1 FY2025, at 2024-06-30$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-05, accession 0000950170-24-090726.Report this figure2.4Current liabilities, Q2 FY2025, at 2024-09-30$2.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure2.9Current liabilities, Q3 FY2025, at 2024-12-31$2.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure3.7Current liabilities, FY2025, at 2025-03-31$3.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-07-14, accession 0001193125-26-303316.Report this figure2.1Current liabilities, Q1 FY2026, at 2025-06-30$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure2.4Current liabilities, Q2 FY2026, at 2025-09-30$2.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure2.5Current liabilities, Q3 FY2026, at 2025-12-31$2.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure2.8Current liabilities, FY2026, at 2026-03-31$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure1.9Current liabilities, Q1 FY2027, at 2026-06-30$1.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Total liabilities$m2.7Total liabilities, Q2 FY2024, at 2023-09-30$2.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062228.Report this figure2.7Total liabilities, Q3 FY2024, at 2023-12-31$2.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-08, accession 0000950170-24-012754.Report this figure2.7Total liabilities, FY2024, at 2024-03-31$2.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-06-05, accession 0000950170-25-082312.Report this figure2.8Total liabilities, Q1 FY2025, at 2024-06-30$2.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-05, accession 0000950170-24-090726.Report this figure3.1Total liabilities, Q2 FY2025, at 2024-09-30$3.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure3.5Total liabilities, Q3 FY2025, at 2024-12-31$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure4.2Total liabilities, FY2025, at 2025-03-31$4.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-07-14, accession 0001193125-26-303316.Report this figure2.4Total liabilities, Q1 FY2026, at 2025-06-30$2.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure2.6Total liabilities, Q2 FY2026, at 2025-09-30$2.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure2.5Total liabilities, Q3 FY2026, at 2025-12-31$2.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure8.5Total liabilities, FY2026, at 2026-03-31$8.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure6.2Total liabilities, Q1 FY2027, at 2026-06-30$6.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Shareholders' equity$m8.5Shareholders' equity, Q2 FY2024, at 2023-09-30$8.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-09, accession 0000950170-23-062228.Report this figure6.2Shareholders' equity, Q3 FY2024, at 2023-12-31$6.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-02-08, accession 0000950170-24-012754.Report this figure3.6Shareholders' equity, FY2024, at 2024-03-31$3.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-06-05, accession 0000950170-25-082312.Report this figure6.7Shareholders' equity, Q1 FY2025, at 2024-06-30$6.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-05, accession 0000950170-24-090726.Report this figure3.7Shareholders' equity, Q2 FY2025, at 2024-09-30$3.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure0.4Shareholders' equity, Q3 FY2025, at 2024-12-31$364.0k. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-06-05, accession 0000950170-25-082312.Report this figure10.5Shareholders' equity, FY2025, at 2025-03-31$10.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-07-14, accession 0001193125-26-303316.Report this figure9.5Shareholders' equity, Q1 FY2026, at 2025-06-30$9.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure7.1Shareholders' equity, Q2 FY2026, at 2025-09-30$7.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure4.4Shareholders' equity, Q3 FY2026, at 2025-12-31$4.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure(1.1)Shareholders' equity, FY2026, at 2026-03-31−$1.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure(2.3)Shareholders' equity, Q1 FY2027, at 2026-06-30−$2.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure

Cash flow

Operating cash flow−$3.2m, Q1 FY2027
Capital expenditure$23.0k, Q1 FY2027
VivoSim Labs, INC., cash flow, quarterly
Line itemUnitQ2 FY20242023-09-30Q3 FY20242023-12-31Q4 FY20242024-03-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30
Operating cash flow$k(3,149)Operating cash flow, Q2 FY2024, three months to 2023-09-30−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0000950170-24-124044. Derived: 6-month figure less the 3-month figure.Report this figure(3,522)Operating cash flow, Q3 FY2024, three months to 2023-12-31−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-19, accession 0000950170-25-022778. Derived: 9-month figure less the 6-month figure.Report this figure(2,671)Operating cash flow, Q4 FY2024, three months to 2024-03-31−$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-06-05, accession 0000950170-25-082312. Derived: 12-month figure less the 9-month figure.Report this figure(2,983)Operating cash flow, Q1 FY2025, three months to 2024-06-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure(2,642)Operating cash flow, Q2 FY2025, three months to 2024-09-30−$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269483. Derived: 6-month figure less the 3-month figure.Report this figure(1,801)Operating cash flow, Q3 FY2025, three months to 2024-12-31−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-11, accession 0001193125-26-046520. Derived: 9-month figure less the 6-month figure.Report this figure(2,035)Operating cash flow, Q4 FY2025, three months to 2025-03-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure(3,940)Operating cash flow, Q1 FY2026, three months to 2025-06-30−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure(2,378)Operating cash flow, Q2 FY2026, three months to 2025-09-30−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269483. Derived: 6-month figure less the 3-month figure.Report this figure(2,271)Operating cash flow, Q3 FY2026, three months to 2025-12-31−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-11, accession 0001193125-26-046520. Derived: 9-month figure less the 6-month figure.Report this figure(2,238)Operating cash flow, Q4 FY2026, three months to 2026-03-31−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure(3,213)Operating cash flow, Q1 FY2027, three months to 2026-06-30−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Capital expenditure$k27.0Capital expenditure, Q2 FY2024, three months to 2023-09-30$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-08, accession 0000950170-24-124044. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-02-19, accession 0000950170-25-022778. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-06-05, accession 0000950170-25-082312. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-08-05, accession 0000950170-24-090726.Report this figure13.0Capital expenditure, Q2 FY2025, three months to 2024-09-30$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269483. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-11, accession 0001193125-26-046520. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269483. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-11, accession 0001193125-26-046520. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-07-14, accession 0001193125-26-303316. Derived: 12-month figure less the 9-month figure.Report this figure23.0Capital expenditure, Q1 FY2027, three months to 2026-06-30$23.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure
Share repurchases$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)5.24m, Q1 FY2027
VivoSim Labs, INC., shares, quarterly
Line itemUnitQ2 FY20232022-09-30Q3 FY20232022-12-31Q1 FY20242023-06-30Q2 FY20242023-09-30Q3 FY20242023-12-31Q1 FY20252024-06-30Q2 FY20252024-09-30Q3 FY20252024-12-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q1 FY20272026-06-30
Diluted shares (weighted)k shares8,712Diluted shares (weighted), Q2 FY2023, three months to 2022-09-308,712,284 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062228.Report this figure8,714Diluted shares (weighted), Q3 FY2023, three months to 2022-12-318,713,617 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-08, accession 0000950170-24-012754.Report this figure8,717Diluted shares (weighted), Q1 FY2024, three months to 2023-06-308,717,232 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-05, accession 0000950170-24-090726.Report this figure8,719Diluted shares (weighted), Q2 FY2024, three months to 2023-09-308,718,502 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-08, accession 0000950170-24-124044.Report this figure9,115Diluted shares (weighted), Q3 FY2024, three months to 2023-12-319,115,455 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-19, accession 0000950170-25-022778.Report this figure1,222Diluted shares (weighted), Q1 FY2025, three months to 2024-06-301,221,974 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-107284.Report this figure1,500Diluted shares (weighted), Q2 FY2025, three months to 2024-09-301,499,544 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure1,505Diluted shares (weighted), Q3 FY2025, three months to 2024-12-311,504,713 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure2,504Diluted shares (weighted), Q1 FY2026, three months to 2025-06-302,503,697 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure2,605Diluted shares (weighted), Q2 FY2026, three months to 2025-09-302,604,950 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269483.Report this figure2,608Diluted shares (weighted), Q3 FY2026, three months to 2025-12-312,607,962 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-11, accession 0001193125-26-046520.Report this figure5,239Diluted shares (weighted), Q1 FY2027, three months to 2026-06-305,239,462 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure

Shares outstanding: 14.85mShares outstanding, period not labelled, at 2026-08-1014,850,612 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-346820.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.